Phillippe Armand
Impact in
- Virology top 5%
- HIV Research and Treatment
-
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
- Oncology 6
- CAR-T cell therapy research 4
- Cancer Immunotherapy and Biomarkers 4
-
- Lymphoma Diagnosis and Treatment 5
- Co-authors
- RJ Soiffer (2 shared papers)Vincent T. Ho (2 shared papers)Françoise Giguel (1 shared paper)Ann S. LaCasce (1 shared paper)Michael P. Busch (1 shared paper)Zixin Hu (1 shared paper)Nina Lin (1 shared paper)Gaia Sciaranghella (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Haematologica (2 papers)The Journal of Infectious Diseases (1 paper)Kölner Universitäts PublikationsServer (Universität zu Köln) (3 papers)
- Partner nations
- United StatesItalyFrance
In The Last Decade
Phillippe Armand
10 papers receiving 260 citations
Peers
Comparison fields: 5 of 41
- Virology 157
- Infectious Diseases 109
- Transplantation 11
- Hematology 45
- Immunology 83
Countries citing papers authored by Phillippe Armand
This map shows the geographic impact of Phillippe Armand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillippe Armand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillippe Armand more than expected).
Fields of papers citing papers by Phillippe Armand
This network shows the impact of papers produced by Phillippe Armand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillippe Armand. The network helps show where Phillippe Armand may publish in the future.
Co-authors
The 25 scholars most cited alongside Phillippe Armand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 182 | |
| 2 | 2016 | 49 | |
| 3 | 2014 | 16 | |
| 4 | 2015 | 6 | |
| 5 | CHECKMATE 205: A PHASE 2 STUDY OF NIVOLUMAB IN PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION AND BRENTUXIMAB VEDOTIN | 2016 | 3 |
| 6 | Multicohort phase 2 study of pembrolizumab for relapsed/refractory classical Hodgkin lymphoma (R/R Chl): Keynote-087. | 2016 | 3 |
| 7 | 2014 | 3 | |
| 8 | 2017 | 1 | |
| 9 | 2015 | 1 | |
| 10 | CHECKMATE 205 COHORT C: NIVOLUMAB IN PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA AFTER PRIOR BRENTUXIMAB VEDOTIN AND AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION | 2016 | 1 |
About Phillippe Armand
Phillippe Armand is a scholar working on Oncology, Pathology and Forensic Medicine, Genetics, Hematology and Immunology, having authored 10 papers that have together received 265 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Immunotherapy and Immune Responses (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), HIV Research and Treatment (1 paper) and Cytomegalovirus and herpesvirus research (1 paper). The work is most often cited by research in Virology (157 citations), Infectious Diseases (109 citations), Transplantation (11 citations), Hematology (45 citations) and Immunology (83 citations). Phillippe Armand has collaborated with scholars based in United States, Italy and France. Frequent co-authors include RJ Soiffer, Vincent T. Ho, Françoise Giguel, Ann S. LaCasce, Michael P. Busch, Zixin Hu, Nina Lin, Gaia Sciaranghella, Sheila M. Keating and Sébastien Gallien. Their work appears in journals such as Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer, Haematologica, The Journal of Infectious Diseases and Kölner Universitäts PublikationsServer (Universität zu Köln).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.